|
|
|
|
|
|
|
|
|
|
Previous: ALPHARMA INC, 10-Q/A, 2000-12-04 |
Next: ALPHARMA INC, 8-K/A, 2000-12-04 |
<TABLE> <S> <C>
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> SEP-30-1999
<CASH> 23,305
<SECURITIES> 0
<RECEIVABLES> 187,563
<ALLOWANCES> 0
<INVENTORY> 159,005
<CURRENT-ASSETS> 382,856
<PP&E> 420,278
<DEPRECIATION> 174,034
<TOTAL-ASSETS> 1,169,430
<CURRENT-LIABILITIES> 180,676
<BONDS> 365,009
0
0
<COMMON> 5,573
<OTHER-SE> 291,464
<TOTAL-LIABILITY-AND-EQUITY> 1,169,430
<SALES> 517,995
<TOTAL-REVENUES> 517,995
<CGS> 283,970
<TOTAL-COSTS> 283,970
<OTHER-EXPENSES> 167,478
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 27,580
<INCOME-PRETAX> 39,215
<INCOME-TAX> 14,276
<INCOME-CONTINUING> 24,939
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 24,939
<EPS-BASIC> .91
<EPS-DILUTED> .88
</TABLE>
|
|